drugset / Trial / NCT00358748
Early Use of Hydrocortisone in Hypotensive Very Low Birth Weight Infants
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the early use of hydrocortisone in hypotensive very low birth weight infants. Based on the observations that: * hypotension is a common problem in very low birthweight infants and is associated with brain injury and poor neurological outcomes; * some infants are refractory to standard treatment (volume expansion and vasopressors), which is not exempt of adverse effects; * relative adrenal insufficiency has been described in this population; we hypothesize that hydrocortisone is effective in the treatment of hypotension in this population and reduce the need for vasopressors.
Timeline
- Start
- 2005-07
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrocortisone | Other / unclassified | 0.5 mg/kg | Intravenous |
Indications
No indication recorded.